Results 121 to 130 of about 14,865 (241)

AB1038 Pharmacokinetics, pharmacodynamics and safety of nc-2500, a novel xanthine oxidoreductase inhibitor, in healthy japanese male subjects [PDF]

open access: bronze, 2018
M. Hirano   +5 more
openalex   +1 more source

Xanthine Oxidoreductase Mediates Nitrite-Induced Platelet Inhibition

open access: yes, 2020
Xanthine oxidoreductase (XOR) is a potential missing link in platelet hyperactivity and cardiovascular diseases. Bioconversion of NO2- to NO by XOR modulates platelet reactivity as we observed rises in plasma NO2- levels after Xdh allele deletion in mice.
Parakaw, Tipparat   +2 more
openaire   +1 more source

Disrupted NAD(P) Metabolism and Xanthine Dehydrogenase in a Stress-Induced Rat Model of Depression: NMR Metabolomics Insights

open access: yesMetabolites
Background: Clinical findings have shown a negative correlation between the severity of depressive symptoms and serum uric acid levels in men, yet the role of metabolic regulation in the pathophysiology of depression remains largely unknown.
Songjiao Chen   +6 more
doaj   +1 more source

Lymphocyte Xanthine Oxidoreductase: Activity vs Extraarticular Manifestations in Rheumatoid Arthritis

open access: diamond, 2022
С. А. Бедина   +6 more
openalex   +1 more source

Comparative characteristics of blood xanthine oxidoreductase profiles in discoid and systemic lupus erythematosus

open access: yesСибирский научный медицинский журнал
Discoid (DLE) and systemic lupus erythematosus (SLE) are chronic inflammatory diseases of the connective tissue. Along with pathogenetic features, they have common characteristics. Immune disorders and oxidative stress are involved in pathogenesis of DLE
E. E. Mozgovaya   +5 more
doaj   +1 more source

Xanthine oxidoreductase in essential hypertension and metabolic syndrome : Experimental studies on rodent models [PDF]

open access: yes, 2009
Hypertension, obesity, dyslipidemia and dysglycemia constitute metabolic syndrome, a major public health concern, which is associated with cardiovascular mortality.
Laakso, Juha
core  

Home - About - Disclaimer - Privacy